Sudeep Pharma IPO GMP: Latest Updates, Listing Price & Subscription Details
The Sudeep Pharma IPO has grabbed the attention of investors as one of the notable pharmaceutical IPOs of 2025. With strong fundamentals and growing market presence, it is expected to generate significant investor interest. Here's everything you need to know about Sudeep Pharma IPO GMP, price band, lot size, and expected listing.
Overview of Sudeep Pharma IPO
Sudeep Pharma is coming up with a book-built IPO worth ₹895 crores. The issue comprises:
Fresh issue: 0.16 crore shares worth ₹95 crores
Offer for sale (OFS): 1.35 crore shares worth ₹800 crores
The IPO aims to raise capital for business expansion while providing existing shareholders a chance to partially exit.
Important dates:
IPO Opening Date: Nov 21, 2025
IPO Closing Date: Nov 25, 2025
Allotment Date: Nov 26, 2025
Tentative Listing Date: Nov 28, 2025 (BSE & NSE)
Sudeep Pharma IPO Price Band & Lot Size
The price band for the IPO is set at ₹563 – ₹593 per share. Investors can apply as follows:
Retail Investors: 1 lot = 25 shares; minimum investment ₹14,825 (at ₹593 per share)
Small HNI (sNII): 14 lots = 350 shares; investment ₹2,07,550
Big HNI (bNII): 68 lots = 1,700 shares; investment ₹10,08,100
Sudeep Pharma IPO GMP – Grey Market Price
The Sudeep Pharma IPO GMP (Grey Market Premium) is a critical indicator for investors looking to gauge listing sentiment.
Latest GMP: ₹109 (as of Nov 21, 2025, 10:57 AM)
Estimated Listing Price: ₹702 per share (upper cap ₹593 + GMP ₹109)
Expected Gain: Approximately 18.38% per share
Grey market activities suggest a positive trend for the IPO, with daily GMP updates showing strong investor demand.
Retail & HNI Subject to Sauda:
Retail: ₹2,100
Small HNI: ₹29,400
GMP Trend:
Lowest GMP recorded: ₹0.00
Highest GMP recorded: ₹130.00
Investors should follow daily updates to track Sudeep Pharma IPO GMP and plan their subscription strategy.
Why Sudeep Pharma IPO is Catching Investor Attention
Strong pharma market potential: The pharmaceutical sector continues to grow steadily with increasing domestic and export demand.
Healthy financials: Sudeep Pharma has a robust revenue model, making it attractive for long-term investors.
Positive grey market signals: The upward GMP trend indicates strong listing potential, boosting confidence among retail and institutional investors.
How to Apply for Sudeep Pharma IPO
Investors can apply through:
ASBA (Application Supported by Blocked Amount) via banks
Online trading platforms provided by brokers
Ensure you apply before Nov 25, 2025, to be eligible for allotment.
Conclusion
The Sudeep Pharma IPO is shaping up to be a strong listing in November 2025. With a promising GMP, positive grey market trends, and solid fundamentals, investors are watching it closely for potential gains. Staying updated with Sudeep Pharma IPO GMP can help you make informed subscription decisions and estimate listing profits.
Stay connected with us for daily GMP updates and detailed analysis of Sudeep Pharma IPO to maximize your investment strategy.
Post a Comment